Sunzen Group Berhad (KLSE:SUNZEN)

Malaysia flag Malaysia · Delayed Price · Currency is MYR
0.245
-0.005 (-2.00%)
At close: Mar 9, 2026
-19.67%
Market Cap 186.22M
Revenue (ttm) 80.19M
Net Income (ttm) 7.71M
Shares Out 760.10M
EPS (ttm) 0.01
PE Ratio 29.31
Forward PE n/a
Dividend 0.00 (1.63%)
Ex-Dividend Date Dec 12, 2025
Volume 30,000
Average Volume 981,785
Open 0.245
Previous Close 0.250
Day's Range 0.245 - 0.245
52-Week Range 0.245 - 0.350
Beta 0.32
RSI 41.08
Earnings Date Feb 24, 2026

About Sunzen Group Berhad

Sunzen Group Berhad, an investment holding company, engages in the biotechnology research and development, manufacturing, and marketing of animal feed supplement products in Malaysia, China, Singapore, and internationally. It operates through Human Health, Medical Devices and Services, and Loan Financing segments. The company provides veterinary, pharmaceutical, chemical products, animal health, and beauty and cosmetic products. It also offers financial consultancy services and licensed money lending activities; manufactures and sells tradition... [Read more]

Industry Pharmaceutical Preparations
Founded 1998
Employees 168
Stock Exchange Bursa Malaysia
Ticker Symbol SUNZEN
Full Company Profile

Financial Performance

In fiscal year 2025, Sunzen Group Berhad's revenue was 80.58 million, a decrease of -15.28% compared to the previous year's 95.12 million. Earnings were 2.59 million, a decrease of -57.10%.

Financial Statements

News

There is no news available yet.